Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren, Ang Li, Jianwen Jiang, et al.
Gut (2018) Vol. 68, Iss. 6, pp. 1014-1023
Open Access | Times Cited: 596

Showing 26-50 of 596 citing articles:

Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Yuxi Yi, Lijun Shen, Wei Shi, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 5, pp. 1329-1340
Open Access | Times Cited: 142
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Hechen Huang, Zhigang Ren, Xingxing Gao, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 141
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Cheng Kong, Lei Liang, Guang Liu, et al.
Gut (2022) Vol. 72, Iss. 6, pp. 1129-1142
Closed Access | Times Cited: 136
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 130
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 116
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Virender Kumar, Xiaofei Xin, Jingyi Ma, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113888-113888
Open Access | Times Cited: 109
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 104
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 83
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
Karolina Kaźmierczak-Siedlecka, Karolina Skonieczna‐Żydecka, Ted R. Hupp, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis
Yibin Che, Guoyu Chen, Qianqian Guo, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 88-102
Closed Access | Times Cited: 46
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Gut–liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice
Xueliang Wang, Yi Fang, Wei Liang, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 7
The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access | Times Cited: 2
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Alterations of the Human Gut Microbiome in Chronic Kidney Disease
Zhigang Ren, Yajuan Fan, Ang Li, et al.
Advanced Science (2020) Vol. 7, Iss. 20
Open Access | Times Cited: 133
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
Marica Meroni, Miriam Longo, Paola Dongiovanni
Nutrients (2019) Vol. 11, Iss. 11, pp. 2642-2642
Open Access | Times Cited: 120
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Hiroshi Fukui
Diseases (2019) Vol. 7, Iss. 4, pp. 58-58
Open Access | Times Cited: 110
Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
Yongbin Zeng, Shanjian Chen, Ya Fu, et al.
Journal of Viral Hepatitis (2019) Vol. 27, Iss. 2, pp. 143-155
Closed Access | Times Cited: 109
Role of Gut Microbiota in Hepatocarcinogenesis
Haripriya Gupta, Gi Soo Youn, Min Jea Shin, et al.
Microorganisms (2019) Vol. 7, Iss. 5, pp. 121-121
Open Access | Times Cited: 108
Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma
Jiajia Ni, Rong Huang, Huifang Zhou, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 104
Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria
Xingxing Jian, Yinghong Zhu, Jian Ouyang, et al.
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 103
Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis
Zhigang Ren, Xinmei Chen, Liangjie Hong, et al.
Small (2019) Vol. 16, Iss. 2
Open Access | Times Cited: 99
Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis
Xinhuan Su, Ying Zhao, Yang Li, et al.
Clinical Science (2020) Vol. 134, Iss. 12, pp. 1521-1535
Open Access | Times Cited: 96
Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus
Xing Wang, Hongli Liu, Yifan Li, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1840765-1840765
Open Access | Times Cited: 94
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 12, pp. 4232-4250
Open Access | Times Cited: 93

Scroll to top